| Factor Information | |
|---|---|
| Data ID | 479 |
| Factor | female sex |
| Description | GSE positively predicted health status and quality of life, and negatively predicted symptoms of anxiety and depression, with an additional explained variance up to 13.6%. |
| Biomarker | NA |
| Classification | E5 (physiological factor - gender) |
| Association | |
|---|---|
| Application | Prognosis |
| Objective | medical predictors |
| p Value | 0.025 |
| Conclusion | Univariate analysis showed that GSE scores were significantly lower among women (p=0.025), in patients who were unemployed, job seeking or on disability (p=0.001), or in NYHA Class III or IV (p=0.048). When performing multivariable linear regression analysis, only gender and NYHA class turned out to be significant correlates of GSE. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 29661025 |
| Year | 2018 |
| Title | Self-efficacy as a predictor of patient-reported outcomes in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | General Self-Efficacy (GSE) scale | |
| Region | Toronto, Canada & Bern, Switzerland | |
| Method | univariate demographic, Hierarchical multivariable linear regression analysis | |
| Race | North America & Europe | |
| Disease History | Any history of arrhythmia 134 (29.5%) | |
| Treatment History | cardiac surgery | |
| Group | male(Treatment) | female(Control) |
| Number | 206 (total:454) | 248 (total:454) |
| Age | median age 32 years, range: 18–81) | median age 32 years, range: 18–81) |
| Gender (Male: Female) | 0:206 | 248:0 |
| Marker Level | Mean GSE (± standard deviation): 30.6 (±4.9) | Mean GSE (± standard deviation): 29.5 (±5.4) |
